← Back to Patent Explorer
US4734410A Expired / Lapsed US ⏱️ 0.0 years remaining

Lactam derivatives and their use as hypotensive agents

Assignee: Sankyo Co Ltd
•
Filing: 1986-10-09
•
Granted: 1988-03-29
•
Expires: 2006-10-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of formula (I): <IMAGE> (I) (wherein R1 and R3 are organic groups, A is a direct bond, -CH2-, -CH2CH2-, -CO-CH2, -O-CH2- or -S-CH2-, B is lower alkylene and n is 1-3) are valuable hypotensive agents which may be prepared by a condensation reaction of the corresponding compound having an amino group at the 3-position.

Inventors

  • 👤 Hiroaki Yanagisawa
  • 👤 Sadao Ishihara
  • 👤 Akiko Ando
  • 👤 Takuro Kanazaki
  • 👤 Hiroyuki Koike
  • 👤 Yasuteru Iijima

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 05:19
CPC Classifications
C; C07; C07D; C07D225/00; C07D225/02; C07K; C07K5/00; C07K5/02; C07K5/022; C07K5/0222; A; A61; A61P; A61P43/00; A61P9/00; A61P9/12; C07D223/00; C07D223/02; C07D223/06; C07D223/12; A61K; A61K38/00; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 44
Claim 1
Independent Claim 483 words
A compound of formula (I): ##STR9## in which: R 1 represents a C 1 -C 10 alkyl group, a C 3 -C 8 cycloalkyl group, an aryl group or a heterocyclic group, or said alkyl group having at least one substituent selected from the group consisting of substituents (a) or said cycloalkyl, aryl or heterocyclic group having at least one substituent selected from the group consisting of substituents (a) and substituents (b); R 3 represents a C 1 -C 10 alkyl group, a C 3 -C 8 cycloalkyl group, an aralkyl group wherein the alkyl part is C 1 -C 6 alkyl, an aryl group, a C 1 -C 6 alkyl group having a heterocyclic substituent or a heterocyclic group, where said heterocyclic group or said heterocyclic substituent is selected from the group consisting of tetrahydrofuranyl, tetrahydrothienyl, tetrahydropyranyl, morpholinyl, furyl, thienyl, imidazolyl, thiazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, pyridyl, quinolyl, isoquinolyl and indolyl, or said alkyl group having at least one substituent selected from the group consisting of substituents (a) or said cycloalkyl, aryl or heterocyclic group having at least one substituent selected from the group consisting of substituents (a) and (b); A represents a single bond, a methylene group, an ethylene group or a group of formula --CO--CH 2 --, --O--CH 2 -- or --S--CH 2 --; B represents an alkylene group having from 1 to 4 carbon atoms; n is an integer from 1 to 3; substituents (a) are: hydroxy groups, C 1 -C 6 alkoxy groups, an aryl group having from 0 to 3 substituents selected from the group consisting of substituents (a) and substituents (b), aralkyloxy groups where the alkyl part is C 1 -C 6 alkyl and the aryl part has from 0 to 3 substituents selected from the group consisting of substituents (a) and (b), aryloxy groups, halogen atoms, nitro groups, cyano groups, carboxy groups, alkoxycarbonyl groups having a total of from 2 to 7 carbon atoms, amino groups, C 1 -C 6 alkylamino groups, dialkylamino groups wherein each alkyl part is C 1 -C 6 alkyl, C 1 -C 6 aliphatic or carbocyclic aryl acylamino groups carbamoyl groups, alkylcarbamoyl groups where the alkyl part is C 1 -C 6 alkyl, dialkylcarbamoyl groups where each alkyl part is C 1 -C 6 alkyl, mercapto groups, C 1 -C 6 alkylthio groups, arylthio groups, C 1 -C 6 alkylsulfonyl groups and arylsulfonyl groups wherein the aryl part has from 0 to 3 C 1 -C 6 alkyl substituents; substituents (b) are: C 1 -C 6 alkyl groups and aralkyl groups wherein the alkyl part is C 1 -C 6 alkyl and the aryl part has from 0 to 3 substituents selected from the group consisting of substituents (a) and substituents (b); and said aryl and said aryl part of said aralkyl, aralkyloxy, aryloxy, aryl acylamino, arylthio or arylsulfonyl is phenyl or naphthyl; and pharmaceutically acceptable salts and esters thereof.
Claim 2
Dependent Claim 483 words
A compound of formula (I): ##STR9## in which: R 1 represents a C 1 -C 10 alkyl group, a C 3 -C 8 cycloalkyl group, an aryl group or a heterocyclic group, or said alkyl group having at least one substituent selected from the group consisting of substituents (a) or said cycloalkyl, aryl or heterocyclic group having at least one substituent selected from the group consisting of substituents (a) and substituents (b); R 3 represents a C 1 -C 10 alkyl group, a C 3 -C 8 cycloalkyl group, an aralkyl group wherein the alkyl part is C 1 -C 6 alkyl, an aryl group, a C 1 -C 6 alkyl group having a heterocyclic substituent or a heterocyclic group, where said heterocyclic group or said heterocyclic substituent is selected from the group consisting of tetrahydrofuranyl, tetrahydrothienyl, tetrahydropyranyl, morpholinyl, furyl, thienyl, imidazolyl, thiazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, pyridyl, quinolyl, isoquinolyl and indolyl, or said alkyl group having at least one substituent selected from the group consisting of substituents (a) or said cycloalkyl, aryl or heterocyclic group having at least one substituent selected from the group consisting of substituents (a) and (b); A represents a single bond, a methylene group, an ethylene group or a group of formula --CO--CH 2 --, --O--CH 2 -- or --S--CH 2 --; B represents an alkylene group having from 1 to 4 carbon atoms; n is an integer from 1 to 3; substituents (a) are: hydroxy groups, C 1 -C 6 alkoxy groups, an aryl group having from 0 to 3 substituents selected from the group consisting of substituents (a) and substituents (b), aralkyloxy groups where the alkyl part is C 1 -C 6 alkyl and the aryl part has from 0 to 3 substituents selected from the group consisting of substituents (a) and (b), aryloxy groups, halogen atoms, nitro groups, cyano groups, carboxy groups, alkoxycarbonyl groups having a total of from 2 to 7 carbon atoms, amino groups, C 1 -C 6 alkylamino groups, dialkylamino groups wherein each alkyl part is C 1 -C 6 alkyl, C 1 -C 6 aliphatic or carbocyclic aryl acylamino groups carbamoyl groups, alkylcarbamoyl groups where the alkyl part is C 1 -C 6 alkyl, dialkylcarbamoyl groups where each alkyl part is C 1 -C 6 alkyl, mercapto groups, C 1 -C 6 alkylthio groups, arylthio groups, C 1 -C 6 alkylsulfonyl groups and arylsulfonyl groups wherein the aryl part has from 0 to 3 C 1 -C 6 alkyl substituents; substituents (b) are: C 1 -C 6 alkyl groups and aralkyl groups wherein the alkyl part is C 1 -C 6 alkyl and the aryl part has from 0 to 3 substituents selected from the group consisting of substituents (a) and substituents (b); and said aryl and said aryl part of said aralkyl, aralkyloxy, aryloxy, aryl acylamino, arylthio or arylsulfonyl is phenyl or naphthyl; and pharmaceutically acceptable salts and esters thereof.
Claim 3
Dependent Claim 90 words
The compound as claimed in claim 1, having the formula (Ia): ##STR10## wherein R 1 , R 3 , A, B and n are as defined in claim 1 and R 2 and R 4 are independently selected from the group consisting of hydrogen C 1 -C 6 alkyl, benzyl, benzhydryl, 1-indanyl, 2-indanyl, 1- or 2-(1,2,3,4-tetrahydronaphthyl), phthalidyl, phenyl, naphthyl, tri(C 1 -C 4 alkyl)silyl, 2,2,2-trichloroethyl, 2-iodoethyl, 2-hydroxyethyl, 2,3-dihydroxypropyl, methoxymethyl, 2-methoxyethoxymethyl, p-methoxybenzyl, acetoxymethyl, 1-acetoxyethyl, pivaloyloxymethyl, phenacyl, methoxycarbonylmethyl, ethoxycarbonylethyl, ethoxycarbonyloxymethyl, 1-(ethoxycarbonyloxy)ethyl, p-nitrobenzyl, 1-cyanoethyl, 2-cyanoethyl, methylthiomethyl, ethylthiomethyl, phenylthiomethyl, 2-methanesulfonylethyl, 2-benzenesulfonylethyl, (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl, and (5-phenyl-2-oxo-1,3-dioxolen-4-yl)methyl.
Claim 4
Dependent Claim 263 words
The compound as claimed in claim 2, wherein R 2 and R 4 are independently selected from the group consisting of C 1 -C 10 alkyl groups, aralkyl groups in which the aryl part is unsubstituted or substituted as defined in (c) below and the alkyl part is C 1 -C 6 alkyl, aryl groups, phthalidyl groups and substituted silyl groups, said groups represented by R 2 and R 4 being unsubstituted or having at least one substituent selected from the group consisting of: (c) C 1 -C 6 alkyl groups except where the parent group is an alkyl group, halogen atoms, hydroxy groups, C 1 -C 6 alkoxy groups, C 1 -C 3 alkoxy groups substituted by a C 1 -C 6 alkoxy group, C 1 -C 6 aliphatic and aryl acyloxy groups, oxo groups, carboxy groups, alkoxycarbonyl groups where the alkoxy part is C 1 -C 6 alkoxy, alkoxycarbonyloxy groups where the alkoxy part is C 1 -C 6 alkoxy, C 1 -C 6 aliphatic and aryl acylamino groups, nitro groups, cyano groups, amino groups, C 1 -C 6 alkylamino groups, dialkylamino groups where each alkyl part is C 1 -C 6 alkyl, arylamino groups, mercapto groups, C 1 -C 6 alkylthio groups, arylthio groups, C 1 -C 6 alkylsulfonyl groups, arylsulfonyl groups and heterocyclic groups selected from the group consisting of tetrahydrofuranyl, tetrahydrothienyl, tetrahydropyranyl, morpholinyl, furyl, thienyl, imidazolyl, thiazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, pyridyl, quinolyl, isoquinolyl and indolyl, said heterocyclic groups being unsubstituted or having at least one substituent selected from the group consisting of the substituents (a) and (b).
Claim 5
Dependent Claim 65 words
The compound as claimed in claim 2, wherein R 2 represents a hydrogen atom; a straight or branched chain alkyl group having from 1 to 6 carbon atoms; an aralkyl group wherein the alkyl part is C 1 -C 6 alkyl and the aryl part is phenyl or naphthyl or a protecting group selected from the group consisting of acetoxymethyl, pivaloyloxymethyl, phthalidyl, 1-(ethoxycarbonyloxy)ethyl, and (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl.
Claim 6
Dependent Claim 32 words
The compound as claimed in claim 2, wherein R 2 represents a hydrogen atom or a methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, hexyl, benzyl, acetoxymethyl, pivaloyloxymethyl, phthalidyl, 1-(ethoxycarbonyloxy)ethyl or (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl group.
Claim 7
Dependent Claim 25 words
The compound as claimed in claim 2, wherein R 4 represents a t-butyl, methoxymethyl, 2,2,2-trichloroethyl, benzyl, p-methoxybenzyl, diphenylmethyl, acetoxymethyl, pivaloyloxymethyl, 1-(ethoxycarbonyloxy)ethyl, phthalidyl or (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl group.
Claim 8
Dependent Claim 147 words
The compound as claimed in claim 3, wherein: R 1 --A-- represents a straight or branched chain alkyl group having from 4 to 9 carbon atoms; a cycloalkylethyl group in which the cycloalkyl part has 5 or 6 ring carbon atoms; an aralkyl group wherein the alkyl part is C 1 -C 2 alkyl and the aryl part is phenyl or naphthyl; a phenoxymethyl group, a phenylthiomethyl group; a 2-(2-thienyl)ethyl group; a 2-(2-imidazolyl)ethyl group; or a 2-(2-thiazolyl)ethyl group; R 3 represents a straight or branched chain alkyl group having from 1 to 6 carbon atoms; a cycloalkyl group having 5 or 6 ring carbon atoms; an aralkyl group wherein the alkyl part is C 1 -C 2 alkyl and the aryl part is phenyl or naphthyl; an aryl group; a heterocyclylmethyl group; or a heterocyclic group; B represents a methylene group; and n is 2 or 3.
Claim 9
Dependent Claim 138 words
The compound as claimed in claim 2, wherein: R 1 represents a C 4 -C 7 alkyl group, a C 5 -C 6 cycloalkyl group, a phenyl group or a phenyl group having at least one substituent selected from the group consisting of substituents (a) and (b); R 2 represents a hydrogen atom, a C 1 -C 4 alkyl group or a benzyl group; R 3 represents a C 3 -C 6 alkyl group, a phenyl group or a phenyl group having at least one substituent selected from the group consisting of substituents (a) and (b); R 4 represents a hydrogen atom, a C 1 -C 4 alkyl group, a benzyl group, a p-methoxybenzyl group or a diphenylmethyl group; A represents a C 1 or C 2 alkylene group; B represents a methylene group; and n is 2.
Claim 10
Dependent Claim 88 words
The compound as claimed in claim 2, wherein: R 1 represents a butyl group, a pentyl group, a hexyl group, a cyclohexyl group or a phenyl group; R 2 represents a hydrogen atom, a C 2 -C 4 alkyl group or a benzyl group; R 3 represents a phenyl group or a halophenyl group; R 4 represents a hydrogen atom, a C 2 -C 4 alkyl group; a p-methoxybenzyl group or a diphenylmethyl group; A represents an ethylene group; B represents a methylene group; and n is 2.
Claim 11
Dependent Claim 2 words
t-butyl α-[3-(1-ethoxycarbonyl-3-phenylpropylamino)-2-oxo-6-phenylperhydroazepin-1-yl]acetate.
Claim 12
Dependent Claim 2 words
t-butyl α-[3-(1-ethoxycarbonyl-3-phenylpropylamino)-2-oxo-6-phenylperhydroazepin-1-yl]acetate.
Claim 13
Dependent Claim 2 words
α-[3-(1-ethoxycarbonyl-3-phenylpropylamino)-2-oxo-6-phenylperhydroazepin-1-yl]acetic acid.
Claim 14
Dependent Claim 2 words
α-[3-(1-ethoxycarbonyl-3-phenylpropylamino)-2-oxo-6-phenylperhydroazepin-1-yl]acetic acid.
Claim 15
Dependent Claim 2 words
.alpha.-[3-(1-carboxy-3-phenylpropylamino)-2-oxo-6-phenylperhydroazepin-1-yl]acetic acid.
Claim 16
Dependent Claim 2 words
.alpha.-[3-(1-carboxy-3-phenylpropylamino)-2-oxo-6-phenylperhydroazepin-1-yl]acetic acid.
Claim 17
Dependent Claim 2 words
t-butyl α-[3-(1-ethoxycarbonyl-3-phenylpropylamino)-6-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl]acetate.
Claim 18
Dependent Claim 2 words
t-butyl α-[3-(1-ethoxycarbonyl-3-phenylpropylamino)-6-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl]acetate.
Claim 19
Dependent Claim 2 words
α-[3-(1-ethoxycarbonyl-3-phenylpropylamino)-6-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl]acetic acid.
Claim 20
Dependent Claim 2 words
α-[3-(1-ethoxycarbonyl-3-phenylpropylamino)-6-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl]acetic acid.
Claim 21
Dependent Claim 2 words
.alpha.-[3-(1-carboxy-3-phenylpropylamino)-6-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl]acetic acid.
Claim 22
Dependent Claim 2 words
.alpha.-[3-(1-carboxy-3-phenylpropylamino)-6-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl]acetic acid.
Claim 23
Dependent Claim 2 words
t-butyl α-[3-(1-butoxycarbonyl-3-phenylpropylamino)-6-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl]acetate.
Claim 24
Dependent Claim 2 words
t-butyl α-[3-(1-butoxycarbonyl-3-phenylpropylamino)-6-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl]acetate.
Claim 25
Dependent Claim 2 words
α-[3-(1-butoxycarbonyl-3-phenylpropylamino)-6-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl]acetic acid.
Claim 26
Dependent Claim 2 words
α-[3-(1-butoxycarbonyl-3-phenylpropylamino)-6-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl]acetic acid.
Claim 27
Dependent Claim 2 words
t-butyl α-[3-(1-butoxycarbonyl-3-phenylpropylamino)-2-oxo-6-phenylperhydroazepin-1-yl]acetate.
Claim 28
Dependent Claim 2 words
t-butyl α-[3-(1-butoxycarbonyl-3-phenylpropylamino)-2-oxo-6-phenylperhydroazepin-1-yl]acetate.
Claim 29
Dependent Claim 2 words
α-[3-(1-butoxycarbonyl-3-phenylpropylamino)-2-oxo-6-phenylperhydroazepin-1-yl]acetic acid.
Claim 30
Dependent Claim 2 words
α-[3-(1-butoxycarbonyl-3-phenylpropylamino)-2-oxo-6-phenylperhydroazepin-1-yl]acetic acid.
Claim 31
Dependent Claim 2 words
.alpha.-{3(S)-[1(S)-ethoxycarbonyl-3-phenylpropylamino]-2-oxo-6(R)-phenylperhydroazepin-1-yl}acetic acid.
Claim 32
Dependent Claim 2 words
.alpha.-{3(S)-[1(S)-ethoxycarbonyl-3-phenylpropylamino]-2-oxo-6(R)-phenylperhydroazepin-1-yl}acetic acid.
Claim 33
Dependent Claim 2 words
α-{3(S)-[1(S)-carboxy-3-phenylpropylamino]-2-oxo-6(R)-phenylperhydroazepin-1-yl}acetic acid.
Claim 34
Dependent Claim 2 words
α-{3(S)-[1(S)-carboxy-3-phenylpropylamino]-2-oxo-6(R)-phenylperhydroazepin-1-yl}acetic acid.
Claim 35
Dependent Claim 2 words
α-{3(S)-[1(S)-ethoxycarbonyl-3-phenylpropylamino]-6(R)-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl}acetic acid.
Claim 36
Dependent Claim 2 words
α-{3(S)-[1(S)-ethoxycarbonyl-3-phenylpropylamino]-6(R)-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl}acetic acid.
Claim 37
Dependent Claim 2 words
α-{3(S)-[1(S)-carboxy-3-phenylpropylamino]-6(R)-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl}acetic acid.
Claim 38
Dependent Claim 2 words
α-{3(S)-[1(S)-carboxy-3-phenylpropylamino]-6(R)-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl}acetic acid.
Claim 39
Dependent Claim 2 words
α-{3(S)-[1(S)-butoxycarbonyl-3-phenylpropylamino]-6(R)-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl}acetic acid.
Claim 40
Dependent Claim 2 words
α-{3(S)-[1(S)-butoxycarbonyl-3-phenylpropylamino]-6(R)-(p-fluorophenyl)-2-oxoperhydroazepin-1-yl}acetic acid.
Claim 41
Dependent Claim 2 words
α-{3(S)-[1(S)-butoxycarbonyl-3-phenylpropylamino]-2-oxo-6(R)-phenylperhydroazepin-1-yl}acetic acid.
Claim 42
Dependent Claim 2 words
α-{3(S)-[1(S)-butoxycarbonyl-3-phenylpropylamino]-2-oxo-6(R)-phenylperhydroazepin-1-yl}acetic acid.
Claim 43
Dependent Claim 55 words
A pharmaceutical composition for the treatment of angiotensin-induced hypertension, which composition comprises an effective amount of a hypotensive agent in admixture with a pharmaceutically acceptable carrier or diluent, wherein said hypotensive agent is selected from the group consisting of compounds of formula (I) and pharmaceutically acceptable salts and esters thereof as claimed in claim 1.
Claim 44
Dependent Claim 48 words
A method of treating angiotensin-induced hypertension in a mammal by administering to said mammal an effective amount of a hypotensive agent, wherein said hypotensive agent is selected from the group consisting of compounds of formula (I) and pharmaceutically acceptable salts and esters thereof as claimed in claim 1.

References Cited (Backward Citations)

EP0046291A2 Cited
US4587050A Cited
US4629787A Cited
US4680392A Cited
EP0161801A2 Cited
US4699905A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-03-29 1991-09-28 1992-03-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-03-29 1995-09-28 1996-03-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-03-29 1999-09-28 2000-03-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag